329 related articles for article (PubMed ID: 27334989)
1. Clonal relationships between lobular carcinoma in situ and other breast malignancies.
Begg CB; Ostrovnaya I; Carniello JV; Sakr RA; Giri D; Towers R; Schizas M; De Brot M; Andrade VP; Mauguen A; Seshan VE; King TA
Breast Cancer Res; 2016 Jun; 18(1):66. PubMed ID: 27334989
[TBL] [Abstract][Full Text] [Related]
2. PIK3CA mutations are common in lobular carcinoma in situ, but are not a biomarker of progression.
Shah V; Nowinski S; Levi D; Shinomiya I; Kebaier Ep Chaabouni N; Gillett C; Grigoriadis A; Graham TA; Roylance R; Simpson MA; Pinder SE; Sawyer EJ
Breast Cancer Res; 2017 Jan; 19(1):7. PubMed ID: 28095868
[TBL] [Abstract][Full Text] [Related]
3. Lobular Carcinomas
Lee JY; Schizas M; Geyer FC; Selenica P; Piscuoglio S; Sakr RA; Ng CKY; Carniello JVS; Towers R; Giri DD; de Andrade VP; Papanastasiou AD; Viale A; Harris RS; Solit DB; Weigelt B; Reis-Filho JS; King TA
Clin Cancer Res; 2019 Jan; 25(2):674-686. PubMed ID: 30185420
[TBL] [Abstract][Full Text] [Related]
4. Clonal relatedness between lobular carcinoma in situ and synchronous malignant lesions.
Andrade VP; Ostrovnaya I; Seshan VE; Morrogh M; Giri D; Olvera N; De Brot M; Morrow M; Begg CB; King TA
Breast Cancer Res; 2012 Jul; 14(4):R103. PubMed ID: 22776144
[TBL] [Abstract][Full Text] [Related]
5. The Pathologic Finding of Combined Lobular Carcinoma
Jean-Louis CJ; Masdon J; Smith B; Battles O; Dale P
Am Surg; 2017 May; 83(5):482-485. PubMed ID: 28541858
[TBL] [Abstract][Full Text] [Related]
6. Breast-conserving surgery for pure non-classic lobular carcinoma in situ: A single institution's experience.
Hoffman DI; Zhang PJ; Tchou J
Surg Oncol; 2019 Mar; 28():190-194. PubMed ID: 30851899
[TBL] [Abstract][Full Text] [Related]
7. Gene expression profiling of lobular carcinoma in situ reveals candidate precursor genes for invasion.
Andrade VP; Morrogh M; Qin LX; Olvera N; Giri D; Muhsen S; Sakr RA; Schizas M; Ng CK; Arroyo CD; Brogi E; Viale A; Morrow M; Reis-Filho JS; King TA
Mol Oncol; 2015 Apr; 9(4):772-82. PubMed ID: 25601220
[TBL] [Abstract][Full Text] [Related]
8. Mixed ductal-lobular carcinomas: evidence for progression from ductal to lobular morphology.
McCart Reed AE; Kutasovic JR; Nones K; Saunus JM; Da Silva L; Newell F; Kazakoff S; Melville L; Jayanthan J; Vargas AC; Reid LE; Beesley J; Chen XQ; Patch AM; Clouston D; Porter A; Evans E; Pearson JV; Chenevix-Trench G; Cummings MC; Waddell N; Lakhani SR; Simpson PT
J Pathol; 2018 Apr; 244(4):460-468. PubMed ID: 29344954
[TBL] [Abstract][Full Text] [Related]
9. Synchronous lobular carcinoma in situ and invasive lobular cancer: marker or precursor for invasive lobular carcinoma.
Wallace AS; Xiang D; Hockman L; Arya M; Jeffress J; Wang Z; Dale PS
Eur J Surg Oncol; 2014 Oct; 40(10):1245-9. PubMed ID: 24857380
[TBL] [Abstract][Full Text] [Related]
10. Targeted capture massively parallel sequencing analysis of LCIS and invasive lobular cancer: Repertoire of somatic genetic alterations and clonal relationships.
Sakr RA; Schizas M; Carniello JV; Ng CK; Piscuoglio S; Giri D; Andrade VP; De Brot M; Lim RS; Towers R; Weigelt B; Reis-Filho JS; King TA
Mol Oncol; 2016 Feb; 10(2):360-70. PubMed ID: 26643573
[TBL] [Abstract][Full Text] [Related]
11. [Lobular carcinoma in situ (LCIS): risk factor and precursor of invasive lobular breast cancer].
Aulmann S; Penzel R; Schirmacher P; Sinn HP
Verh Dtsch Ges Pathol; 2007; 91():208-13. PubMed ID: 18314616
[TBL] [Abstract][Full Text] [Related]
12. Pre-operative management of Pleomorphic and florid lobular carcinoma in situ of the breast: Report of a large multi-institutional series and review of the literature.
Foschini MP; Miglio R; Fiore R; Baldovini C; Castellano I; Callagy G; Bianchi S; Kaya H; Amendoeira I; Querzoli P; Poli F; Scatena C; Cordoba A; Pietribiasi F; Kovács A; Faistova H; Cserni G; Quinn C
Eur J Surg Oncol; 2019 Dec; 45(12):2279-2286. PubMed ID: 31301938
[TBL] [Abstract][Full Text] [Related]
13. Pleomorphic lobular carcinoma in situ of the breast: a single institution experience with clinical follow-up and centralized pathology review.
De Brot M; Koslow Mautner S; Muhsen S; Andrade VP; Mamtani A; Murray M; Giri D; Sakr RA; Brogi E; King TA
Breast Cancer Res Treat; 2017 Sep; 165(2):411-420. PubMed ID: 28612228
[TBL] [Abstract][Full Text] [Related]
14. Evaluating the Rate of Upgrade to Invasive Breast Cancer and/or Ductal Carcinoma In Situ Following a Core Biopsy Diagnosis of Non-classic Lobular Carcinoma In Situ.
Nakhlis F; Harrison BT; Giess CS; Lester SC; Hughes KS; Coopey SB; King TA
Ann Surg Oncol; 2019 Jan; 26(1):55-61. PubMed ID: 30362065
[TBL] [Abstract][Full Text] [Related]
15. Clonality of lobular carcinoma in situ (LCIS) and metachronous invasive breast cancer.
Aulmann S; Penzel R; Longerich T; Funke B; Schirmacher P; Sinn HP
Breast Cancer Res Treat; 2008 Feb; 107(3):331-5. PubMed ID: 17380381
[TBL] [Abstract][Full Text] [Related]
16. Genetic relation of lobular carcinoma in situ, ductal carcinoma in situ, and associated invasive carcinoma of the breast.
Buerger H; Simon R; Schäfer KL; Diallo R; Littmann R; Poremba C; van Diest PJ; Dockhorn-Dworniczak B; Böcker W
Mol Pathol; 2000 Jun; 53(3):118-21. PubMed ID: 10897329
[TBL] [Abstract][Full Text] [Related]
17. Risk of Contralateral Breast Cancer in Women with Ductal Carcinoma In Situ Associated with Synchronous Ipsilateral Lobular Carcinoma In Situ.
Miller ME; Muhsen S; Zabor EC; Flynn J; Olcese C; Giri D; Van Zee KJ; Pilewskie M
Ann Surg Oncol; 2019 Dec; 26(13):4317-4325. PubMed ID: 31552614
[TBL] [Abstract][Full Text] [Related]
18. Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) Protocol B-17. Five-year observations concerning lobular carcinoma in situ.
Fisher ER; Costantino J; Fisher B; Palekar AS; Paik SM; Suarez CM; Wolmark N
Cancer; 1996 Oct; 78(7):1403-16. PubMed ID: 8839545
[TBL] [Abstract][Full Text] [Related]
19. Surgical Outcomes of Lobular Neoplasia Diagnosed in Core Biopsy: Prospective Study of 316 Cases.
Susnik B; Day D; Abeln E; Bowman T; Krueger J; Swenson KK; Tsai ML; Bretzke ML; Lillemoe TJ
Clin Breast Cancer; 2016 Dec; 16(6):507-513. PubMed ID: 27425222
[TBL] [Abstract][Full Text] [Related]
20. Hsa-miR-375 is differentially expressed during breast lobular neoplasia and promotes loss of mammary acinar polarity.
Giricz O; Reynolds PA; Ramnauth A; Liu C; Wang T; Stead L; Childs G; Rohan T; Shapiro N; Fineberg S; Kenny PA; Loudig O
J Pathol; 2012 Jan; 226(1):108-19. PubMed ID: 21953071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]